483 related articles for article (PubMed ID: 6676604)
1. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
[TBL] [Abstract][Full Text] [Related]
2. Effects of sustained hyperprolactinemia induced by chronic treatment with domperidone on central dopaminergic systems in the rat.
Benfenati F; Ferretti C; Cimino M; Vantini G; Lipartiti M; Muccioli G; Di Carlo R; Algeri S
Pharmacol Res Commun; 1986 May; 18(5):431-49. PubMed ID: 3737655
[TBL] [Abstract][Full Text] [Related]
3. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
4. Reproductive experience modifies dopaminergic function, serum levels of prolactin, and macrophage activity in female rats.
Carvalho-Freitas MI; Anselmo-Franci JA; Teodorov E; Nasello AG; Palermo-Neto J; Felicio LF
Life Sci; 2007 Jun; 81(2):128-36. PubMed ID: 17574628
[TBL] [Abstract][Full Text] [Related]
5. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
Henderson MG; McMillen BA
Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of inorganic mercury (HgCl(2)) on striatal dopaminergic system.
Faro LR; do Nascimento JL; Alfonso M; Durán R
Ecotoxicol Environ Saf; 2001 Mar; 48(3):263-7. PubMed ID: 11222035
[TBL] [Abstract][Full Text] [Related]
7. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-haloperidol interactions on striatal and mesolimbic tyrosine hydroxylase activity and dopamine metabolism.
Kuczenski R
J Pharmacol Exp Ther; 1980 Oct; 215(1):135-42. PubMed ID: 6109012
[TBL] [Abstract][Full Text] [Related]
9. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
11. Effects of a fluorinated pyrimidinedione anti-cancer drug, 5-fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione (FT), and related compounds on nigro-striatal dopaminergic neurons in the central nervous system.
Toide K; Unemi N; Segawa T
Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):111-24. PubMed ID: 3925907
[TBL] [Abstract][Full Text] [Related]
12. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
[TBL] [Abstract][Full Text] [Related]
13. [Study of the turnover or the release of brain dopamine in rats after administration of N-linoleyl dopamine].
Papadopoulou-Daïfoti Z; Sakellariou A; Raftopoulos C; Vamvakidès A
Ann Pharm Fr; 1992; 50(4):229-36. PubMed ID: 1306617
[TBL] [Abstract][Full Text] [Related]
14. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic mediation of beta-endorphin-induced catalepsy.
Van Loon GR; Kim C
Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
17. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
See RE
Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
[TBL] [Abstract][Full Text] [Related]
18. Riluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
Boireau A; Miquet JM; Dubédat P; Meunier M; Doble A
Neuroreport; 1994 Oct; 5(16):2157-60. PubMed ID: 7865766
[TBL] [Abstract][Full Text] [Related]
19. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
[TBL] [Abstract][Full Text] [Related]
20. [Effect of haloperidol decanoate on the dopaminergic system in the rat brain].
Kashihara K; Fujiwara Y; Harada T; Ogawa T; Sato M; Otsuki S
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):353-8. PubMed ID: 3811625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
